I am a 37-year-old woman with two consecutive pregnancy losses, both occurring

Guideline-aligned answer with reasoning, red flags and references. Clinically reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP.

Posted: 9 July 2026Updated: 9 July 2026 Guideline-Aligned (High Confidence) Clinically Reviewed

Investigation strategies:

  • Since the patient has recurrent pregnancy loss at around 7 weeks, referral for a thorough investigation is recommended to identify underlying causes, including autoimmune conditions such as antiphospholipid syndrome and lupus, which have not yet been tested for in this case .
  • Testing for antiphospholipid syndrome should include lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2 glycoprotein I antibodies, as these are crucial for autoimmune etiology assessment in recurrent miscarriage .
  • Assessment of lupus (systemic lupus erythematosus) through relevant autoantibody panels including ANA (antinuclear antibody) testing should be performed as part of the autoimmune workup .
  • Given the subchorionic hematoma noted by ultrasound, continued ultrasound monitoring of the pregnancy is warranted to assess hematoma size and fetal viability, as transvaginal ultrasound is the diagnostic tool of choice to evaluate early pregnancy loss and complications ,.
  • For the luteal cyst, which may be a benign and common finding in early pregnancy, clinical correlation and sonographic follow-up could be considered but usually does not require intervention unless symptomatic .
  • Elevated fasting blood sugar suggests impaired glucose metabolism or diabetes; therefore, screening for gestational diabetes according to NICE guidelines should be conducted, typically with an oral glucose tolerance test between 24 and 28 weeks gestation . Early referral to diabetes in pregnancy services may be appropriate given the elevated fasting glucose now .

Management strategies:

  • Management of recurrent miscarriage with an autoimmune etiology is tailored; if antiphospholipid syndrome is diagnosed, low-dose aspirin plus heparin therapy during pregnancy is generally recommended to improve live birth rates .
  • In the absence of thrombosis or pregnancy-related hypertensive disorders history, prophylactic anticoagulation or antiplatelet therapy should be based on test results and specialist consultation ,.
  • Subchorionic hematoma may be managed expectantly with close monitoring, advising the patient to report any increase in bleeding or pain, as immediate intervention is typically not required unless complications arise ,.
  • For elevated fasting blood sugar, optimizing glycemic control before and during pregnancy is essential to reduce miscarriage risk and improve maternal and fetal outcomes; this involves lifestyle advice, glucose monitoring, and possible medical therapy under guidance .
  • Regular antenatal visits with blood pressure monitoring should be included, given the risk of pregnancy complications such as pre-eclampsia, especially in women with autoimmune conditions or glucose intolerance .
  • If no cause is found after investigation, women should be counselled that the prognosis for a successful pregnancy remains reasonably good (~75%), but continued surveillance and support are important .

Overall, a multidisciplinary approach with early referral to specialist services including rheumatology (for autoimmune evaluation), maternal-fetal medicine, and endocrinology (for glucose management) is advised to optimize investigation and management in this complex clinical context ,.

Educational content only. Always verify information and use clinical judgement.